Novorex is specialized company in the development of new small molecule drugs targeting mostly oncology and neurology diseases using FBDD and artificial intelligence with pharmaceutical experts. Seamless Drug Discovery is performed using cutting-edge technology that considers the entire process of new drug development. We aim to develop high-efficiency new drugs through drug design that combines biophysical analysis and in vitro/in vivo assay.